BiotechTubeBiotechTube
Home/FibroBiologics/Richard C. Cilento, Jr.
RC

Richard C. Cilento, Jr.

Board of Directors

FibroBiologics

Therapeutic Areas

Degenerative Disc DiseaseMultiple SclerosisWound HealingPsoriasisOncologyDiabetesAnti-Aging / Immunosenescence

FibroBiologics Pipeline

DrugIndicationPhase
CybroCell™Degenerative Disc Disease (DDD)Clinical
CYMS101Multiple SclerosisPre-clinical / Limited Clinical
CYWC628Wound Healing (Diabetic Foot Ulcers, Venous Leg Ulcers, burns)Pre-clinical
CYPS317PsoriasisDiscovery
CYTER915Cancer ImmunotherapyDiscovery
TBC190Thymic Involution ReversalDiscovery
CYAPO913DiabetesDiscovery
Unnamed Spleen ProgramSplenic Involution ReversalDiscovery

Leadership Team at FibroBiologics

PO
Pete O'Heeron
Chairman/Founder/CEO
JD
Jason D. Davis
Chief Financial Officer
HK
Hamid Khoja, Ph.D.
Chief Scientific Officer
RG
Ruben Garcia, JD
General Counsel
RE
Robert E. Hoffman
Board of Directors
SC
Stacy Coen, MBA
Board of Directors
ML
Matt Link
Board of Directors
VN
Victoria Niklas, M.D.
Board of Directors
CL
Claudia Lucchinetti, M.D.
Scientific Advisory Board
ST
S. Thomas Carmichael, M.D., Ph.D.
Scientific Advisory Board
View full FibroBiologics profile